461 related articles for article (PubMed ID: 15355458)
21. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
22. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome.
Kleiber H; Rey F; Temler E; Gomez F
J Endocrinol Invest; 1991 Jun; 14(6):489-92. PubMed ID: 1663528
[TBL] [Abstract][Full Text] [Related]
23. [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect].
Feng C; Li HZ; Xiao H; Yan WG; Li YQ; Xu WF
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1691-3. PubMed ID: 18476528
[TBL] [Abstract][Full Text] [Related]
24. Adrenocortical response to low-dose ACTH test in female patients with rheumatoid arthritis.
Radikova Z; Rovensky J; Vlcek M; Penesova A; Kerlik J; Vigas M; Imrich R
Ann N Y Acad Sci; 2008 Dec; 1148():562-6. PubMed ID: 19120158
[TBL] [Abstract][Full Text] [Related]
25. Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro.
Gröndal S; Grimelius L; Thorén M; Hamberger B
Eur J Surg; 1991 Mar; 157(3):179-83. PubMed ID: 1678626
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and pathophysiology of Cushing's syndrome.
Gabrilove JL; Krakoff LR
Compr Ther; 1986 Jan; 12(1):17-21. PubMed ID: 3004801
[TBL] [Abstract][Full Text] [Related]
27. Critical size of residual adrenal tissue and recovery from impaired early postoperative adrenocortical function after subtotal bilateral adrenalectomy.
Brauckhoff M; Gimm O; Thanh PN; Bär A; Ukkat J; Brauckhoff K; Bönsch T; Dralle H
Surgery; 2003 Dec; 134(6):1020-7; discussion 1027-8. PubMed ID: 14668736
[TBL] [Abstract][Full Text] [Related]
28. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
Ronchi CL; Ferrante E; Rizzo E; Giavoli C; Verrua E; Bergamaschi S; Lania AG; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2008 Oct; 69(4):608-12. PubMed ID: 18410544
[TBL] [Abstract][Full Text] [Related]
29. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
[TBL] [Abstract][Full Text] [Related]
30. DHEA(S)--a novel marker in Cushing's disease.
Burkhardt T; Schmidt NO; Vettorazzi E; Aberle J; Mengel M; Flitsch J
Acta Neurochir (Wien); 2013 Mar; 155(3):479-84; discussion 484. PubMed ID: 23314986
[TBL] [Abstract][Full Text] [Related]
31. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.
Pecori Giraldi F; Scaroni C; Arvat E; Martin M; Giordano R; Albiger N; Leao AA; Picu A; Mantero F; Cavagnini F
Clin Endocrinol (Oxf); 2006 Feb; 64(2):219-24. PubMed ID: 16430724
[TBL] [Abstract][Full Text] [Related]
32. Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors.
Pimentel-Filho FR; Cukiert A; Miyashita F; Huayllas MK; Knoepfelmacher M; Salgado LR; Liberman B
J Endocrinol Invest; 2001 Feb; 24(2):83-7. PubMed ID: 11263476
[TBL] [Abstract][Full Text] [Related]
33. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
Tzanela M; Zianni D; Stylianidou Ch; Karavitaki N; Tsagarakis S; Thalassinos NC
Clin Endocrinol (Oxf); 2005 May; 62(5):597-602. PubMed ID: 15853831
[TBL] [Abstract][Full Text] [Related]
35. Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology.
Berr CM; Di Dalmazi G; Osswald A; Ritzel K; Bidlingmaier M; Geyer LL; Treitl M; Hallfeldt K; Rachinger W; Reisch N; Blaser R; Schopohl J; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1300-8. PubMed ID: 25546155
[TBL] [Abstract][Full Text] [Related]
36. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
37. Plasma cortisol profiles in Cushing's syndrome.
Yoshida K; Satowa H; Sato A; Ichikawa Y; Kream J; Levin J; Zumoff B; Hellman L; Fukushima DK
Acta Endocrinol (Copenh); 1979 Jun; 91(2):319-28. PubMed ID: 223357
[TBL] [Abstract][Full Text] [Related]
38. [Value of basal cortisol and ACTH in the immediate postoperative period of hypophyseal surgery in non-ACTH secretory adenomas].
Camps I; Gómez JM; Bonnin R; Montaña E; Acebes J; Soler J
Med Clin (Barc); 1993 Oct; 101(11):410-3. PubMed ID: 8231355
[TBL] [Abstract][Full Text] [Related]
39. [Importance of the CRH (corticotropin releasing hormone) test in the differential diagnosis of Cushing's syndrome].
Korsić M; Plavsić V; Besenski N; Skorić T; Giljević Z; Zarković K; Zarković N; Zaninović L; Paladino J; Aganović I
Lijec Vjesn; 2001; 123(7-8):165-8. PubMed ID: 11729609
[TBL] [Abstract][Full Text] [Related]
40. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.
Alexandraki KI; Kaltsas GA; le Roux CW; Fassnacht M; Ajodha S; Christ-Crain M; Akker SA; Drake WM; Edwards R; Allolio B; Grossman AB
Clin Endocrinol (Oxf); 2010 Mar; 72(3):305-11. PubMed ID: 19473175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
